VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 6.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $15,000 | +87.5% | 1,416 | +95.6% | 0.00% | – |
| Q1 2022 | $8,000 | -33.3% | 724 | -3.7% | 0.00% | – |
| Q4 2021 | $12,000 | 0.0% | 752 | +5.8% | 0.00% | – |
| Q3 2021 | $12,000 | +71.4% | 711 | +19.9% | 0.00% | -100.0% |
| Q2 2020 | $7,000 | -36.4% | 593 | -44.3% | 0.00% | -80.0% |
| Q1 2020 | $11,000 | +1000.0% | 1,064 | +1734.5% | 0.01% | – |
| Q2 2019 | $1,000 | -94.4% | 58 | -94.1% | 0.00% | -100.0% |
| Q1 2019 | $18,000 | +800.0% | 984 | +720.0% | 0.01% | +250.0% |
| Q4 2017 | $2,000 | +100.0% | 120 | +103.4% | 0.00% | +100.0% |
| Q3 2017 | $1,000 | 0.0% | 59 | +20.4% | 0.00% | 0.0% |
| Q2 2017 | $1,000 | -66.7% | 49 | -77.3% | 0.00% | -66.7% |
| Q4 2016 | $3,000 | – | 216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |